Skip navigation

Chemical Thyroid Hormones

1–50 of 166 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 3-iodotyrosine cell proliferation Nicotine 3-iodotyrosine inhibits the reaction [Nicotine results in increased cell proliferation] 1: Homo sapiens HT29 Cells   1
2. nano-diamino-tetrac negative regulation of phosphatidylinositol 3-kinase activity nano-diamino-tetrac results in increased negative regulation of phosphatidylinositol 3-kinase activity 1: Homo sapiens Mouth | Cell Line, Tumor   1
3. nano-diamino-tetrac negative regulation of phosphatidylinositol 3-kinase activity 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one [nano-diamino-tetrac results in increased susceptibility to 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] which results in increased negative regulation of phosphatidylinositol 3-kinase activity 1: Homo sapiens Mouth | Cell Line, Tumor   1
4. nano-diamino-tetrac negative regulation of phosphatidylinositol 3-kinase activity 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [nano-diamino-tetrac results in increased negative regulation of phosphatidylinositol 3-kinase activity] 1: Homo sapiens Mouth | Cell Line, Tumor   1
5. nano-diamino-tetrac negative regulation of phosphatidylinositol 3-kinase activity 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [nano-diamino-tetrac results in increased negative regulation of phosphatidylinositol 3-kinase activity] 1: Homo sapiens Mouth | Cell Line, Tumor   1
6. nano-diamino-tetrac negative regulation of ERK1 and ERK2 cascade nano-diamino-tetrac results in increased negative regulation of ERK1 and ERK2 cascade 1: Homo sapiens Mouth | Cell Line, Tumor   1
7. nano-diamino-tetrac negative regulation of ERK1 and ERK2 cascade 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one [nano-diamino-tetrac results in increased susceptibility to 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] which results in increased negative regulation of ERK1 and ERK2 cascade 1: Homo sapiens Mouth | Cell Line, Tumor   1
8. nano-diamino-tetrac negative regulation of ERK1 and ERK2 cascade 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [nano-diamino-tetrac results in increased negative regulation of ERK1 and ERK2 cascade] 1: Homo sapiens Mouth | Cell Line, Tumor   1
9. nano-diamino-tetrac negative regulation of cell proliferation nano-diamino-tetrac results in increased negative regulation of cell proliferation 1: Homo sapiens Mouth | Cell Line, Tumor   1
10. nano-diamino-tetrac negative regulation of cell proliferation CD274 CD274 protein inhibits the reaction [nano-diamino-tetrac results in increased negative regulation of cell proliferation] 1: Homo sapiens Mouth | Cell Line, Tumor   1
11. Triiodothyronine cell differentiation Dexamethasone Triiodothyronine affects the reaction [Dexamethasone results in increased cell differentiation] 1: Rattus norvegicus Skull | Cells, Cultured
38 genes: AKT1 | AMH | ATOH7 | BMP2 | BMP6 | BMP7 | CNMD | DLL3 | DLX2 | DMBT1 | EGFL7 | EPAS1 | FGF1 | FGF2 | FGF3 | FGF9 | FGFR3 | FRZB | GAP43 | GLI2 | GPER1 | HIF1A | INHBB | LHX3 | MGP | MYF5 | NKX2-2 | NPNT | NR5A1 | NRP1 | OSGIN1 | PAX2 | PEG10 | PIK3CD | SIRT1 | TMEM100 | TP63 | ZNF3
1
12. Triiodothyronine lipid biosynthetic process Triiodothyronine results in increased lipid biosynthetic process Fetus | Hepatocytes | Cells, Cultured
6 genes: FASN | FDFT1 | INS | SC5D | SCD1 | SREBF1
1
13. Triiodothyronine lipid biosynthetic process Triiodothyronine results in increased lipid biosynthetic process 1: Rattus norvegicus Adipose Tissue, Brown | Adipocytes, Brown
6 genes: FASN | FDFT1 | INS | SC5D | SCD1 | SREBF1
1
14. Triiodothyronine regulation of membrane potential Triiodothyronine affects regulation of membrane potential 1: Rattus norvegicus Submandibular Gland | Cells, Cultured
3 genes: HCN2 | KCNA1 | KCNMA1
1
15. Triiodothyronine apoptotic process Triiodothyronine results in increased apoptotic process 1: Xenopus laevis Intestines | Epithelial Cells
46 genes: ADAM15 | ADRB1 | AHR | AIFM3 | AKT1 | ALDOC | APP | AVP | BAD | BAX | BCL2 | BCL2A1A | BCL2L1 | C1D | CASP3 | CDK1 | CHEK1 | DIO3 | DPF2 | EPB41L3 | FGFR2 | FGFR3 | GH | GJA1 | GPER1 | GULP1 | IRF1 | ITPR1 | KIF1B | LMNB1 | MAPK1 | MAPK3 | MCM2 | NFKB1 | NR3C1 | NR4A1 | PCSK9 | PEG10 | PHLDA2 | RB1 | SIRT1 | TCIM | TNF | TNFRSF9 | TP63 | TRAF1
1
16. Triiodothyronine apoptotic process Cyclosporine Cyclosporine inhibits the reaction [Triiodothyronine results in increased apoptotic process] 1: Xenopus laevis Intestines | Epithelial Cells
46 genes: ADAM15 | ADRB1 | AHR | AIFM3 | AKT1 | ALDOC | APP | AVP | BAD | BAX | BCL2 | BCL2A1A | BCL2L1 | C1D | CASP3 | CDK1 | CHEK1 | DIO3 | DPF2 | EPB41L3 | FGFR2 | FGFR3 | GH | GJA1 | GPER1 | GULP1 | IRF1 | ITPR1 | KIF1B | LMNB1 | MAPK1 | MAPK3 | MCM2 | NFKB1 | NR3C1 | NR4A1 | PCSK9 | PEG10 | PHLDA2 | RB1 | SIRT1 | TCIM | TNF | TNFRSF9 | TP63 | TRAF1
1
17. Triiodothyronine cell cycle tamibarotene Triiodothyronine promotes the reaction [tamibarotene results in decreased cell cycle] 1: Homo sapiens HL-60 Cells
30 genes: AHR | ASPM | CCNA2 | CCNB1 | CCNB2 | CCND1 | CCND2 | CCNE1 | CCNH | CDC45 | CDK1 | CDK7 | CDKN1A | CDKN1B | CHEK1 | CSNK1A1 | GPER1 | H2AFX | ING1 | MAPK1 | MAPK3 | MCM2 | MKI67 | NCAPG2 | NR3C1 | RB1 | S100A6 | SRC | TACC3 | TP63
1
18. Triiodothyronine apoptotic process tamibarotene Triiodothyronine promotes the reaction [tamibarotene results in increased apoptotic process] 1: Homo sapiens HL-60 Cells
46 genes: ADAM15 | ADRB1 | AHR | AIFM3 | AKT1 | ALDOC | APP | AVP | BAD | BAX | BCL2 | BCL2A1A | BCL2L1 | C1D | CASP3 | CDK1 | CHEK1 | DIO3 | DPF2 | EPB41L3 | FGFR2 | FGFR3 | GH | GJA1 | GPER1 | GULP1 | IRF1 | ITPR1 | KIF1B | LMNB1 | MAPK1 | MAPK3 | MCM2 | NFKB1 | NR3C1 | NR4A1 | PCSK9 | PEG10 | PHLDA2 | RB1 | SIRT1 | TCIM | TNF | TNFRSF9 | TP63 | TRAF1
1
19. Triiodothyronine apoptotic process HX 600 [Triiodothyronine co-treated with HX 600] results in increased apoptotic process 1: Homo sapiens HL-60 Cells
46 genes: ADAM15 | ADRB1 | AHR | AIFM3 | AKT1 | ALDOC | APP | AVP | BAD | BAX | BCL2 | BCL2A1A | BCL2L1 | C1D | CASP3 | CDK1 | CHEK1 | DIO3 | DPF2 | EPB41L3 | FGFR2 | FGFR3 | GH | GJA1 | GPER1 | GULP1 | IRF1 | ITPR1 | KIF1B | LMNB1 | MAPK1 | MAPK3 | MCM2 | NFKB1 | NR3C1 | NR4A1 | PCSK9 | PEG10 | PHLDA2 | RB1 | SIRT1 | TCIM | TNF | TNFRSF9 | TP63 | TRAF1
1
20. Triiodothyronine cell differentiation Triiodothyronine affects cell differentiation 2: Homo sapiens | Mus musculus Erythroblasts | Cells, Cultured
38 genes: AKT1 | AMH | ATOH7 | BMP2 | BMP6 | BMP7 | CNMD | DLL3 | DLX2 | DMBT1 | EGFL7 | EPAS1 | FGF1 | FGF2 | FGF3 | FGF9 | FGFR3 | FRZB | GAP43 | GLI2 | GPER1 | HIF1A | INHBB | LHX3 | MGP | MYF5 | NKX2-2 | NPNT | NR5A1 | NRP1 | OSGIN1 | PAX2 | PEG10 | PIK3CD | SIRT1 | TMEM100 | TP63 | ZNF3
1
21. Triiodothyronine cell proliferation Tretinoin [Tretinoin co-treated with Triiodothyronine] results in decreased cell proliferation 2: Homo sapiens | Mus musculus Erythroblasts | Cells, Cultured
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
22. Triiodothyronine cell proliferation EPO | Tretinoin [Tretinoin co-treated with Triiodothyronine] inhibits the reaction [EPO protein results in increased cell proliferation] 1: Mus musculus Granulocyte Precursor Cells | Cell Line, Tumor
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
23. Triiodothyronine cell differentiation EPO Triiodothyronine inhibits the reaction [EPO protein affects cell differentiation] 1: Mus musculus Granulocyte Precursor Cells | Cell Line, Tumor
38 genes: AKT1 | AMH | ATOH7 | BMP2 | BMP6 | BMP7 | CNMD | DLL3 | DLX2 | DMBT1 | EGFL7 | EPAS1 | FGF1 | FGF2 | FGF3 | FGF9 | FGFR3 | FRZB | GAP43 | GLI2 | GPER1 | HIF1A | INHBB | LHX3 | MGP | MYF5 | NKX2-2 | NPNT | NR5A1 | NRP1 | OSGIN1 | PAX2 | PEG10 | PIK3CD | SIRT1 | TMEM100 | TP63 | ZNF3
1
24. Triiodothyronine cellular response to thyroid hormone stimulus Triiodothyronine affects cellular response to thyroid hormone stimulus 1: Rattus norvegicus Pituitary Gland | Cell Line
5 genes: COL1A2 | GH1 | INHBB | KLF9 | PPARGC1A
1
25. Triiodothyronine cellular response to thyroid hormone stimulus Polybrominated Biphenyls Polybrominated Biphenyls inhibits the reaction [Triiodothyronine affects cellular response to thyroid hormone stimulus] 1: Rattus norvegicus Pituitary Gland | Cell Line
5 genes: COL1A2 | GH1 | INHBB | KLF9 | PPARGC1A
1
26. Triiodothyronine cell proliferation Triiodothyronine results in increased cell proliferation 1: Rattus norvegicus Pituitary Gland | Cell Line
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
27. Triiodothyronine cell proliferation perfluorooctane sulfonic acid perfluorooctane sulfonic acid inhibits the reaction [Triiodothyronine results in increased cell proliferation] 1: Rattus norvegicus Pituitary Gland | Cell Line
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
28. Triiodothyronine cell proliferation perfluorononanoic acid perfluorononanoic acid inhibits the reaction [Triiodothyronine results in increased cell proliferation] 1: Rattus norvegicus Pituitary Gland | Cell Line
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
29. Triiodothyronine cell proliferation perfluoroundecanoic acid perfluoroundecanoic acid inhibits the reaction [Triiodothyronine results in increased cell proliferation] 1: Rattus norvegicus Pituitary Gland | Cell Line
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
30. Triiodothyronine cell proliferation perfluorohexanesulfonic acid perfluorohexanesulfonic acid affects the reaction [Triiodothyronine results in increased cell proliferation] 1: Rattus norvegicus Pituitary Gland | Cell Line
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
31. Triiodothyronine regulation of fatty acid oxidation Triiodothyronine affects regulation of fatty acid oxidation Mitochondria
2 genes: CPT1A | PDK4
1
32. Triiodothyronine regulation of gluconeogenesis Triiodothyronine affects regulation of gluconeogenesis Mitochondria
2 genes: NR3C1 | PCK1
1
33. Triiodothyronine cell proliferation Triiodothyronine results in increased cell proliferation 1: Rattus norvegicus Pituitary Gland | Cell Line, Tumor
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
2
34. Triiodothyronine cell proliferation prothioconazole prothioconazole inhibits the reaction [Triiodothyronine results in increased cell proliferation] 1: Rattus norvegicus Pituitary Gland | Cell Line, Tumor
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
35. Triiodothyronine cell proliferation propiconazole propiconazole inhibits the reaction [Triiodothyronine results in increased cell proliferation] 1: Rattus norvegicus Pituitary Gland | Cell Line, Tumor
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
36. Triiodothyronine cell proliferation cypermethrin cypermethrin inhibits the reaction [Triiodothyronine results in increased cell proliferation] 1: Rattus norvegicus Pituitary Gland | Cell Line, Tumor
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
37. Triiodothyronine cell proliferation bitertanol bitertanol inhibits the reaction [Triiodothyronine results in increased cell proliferation] 1: Rattus norvegicus Pituitary Gland | Cell Line, Tumor
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
38. Triiodothyronine cell proliferation fluvalinate fluvalinate analog inhibits the reaction [Triiodothyronine results in increased cell proliferation] 1: Rattus norvegicus Pituitary Gland | Cell Line, Tumor
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
39. Triiodothyronine cell proliferation bitertanol | cypermethrin | Malathion | prothioconazole | terbutylazine [prothioconazole co-treated with terbutylazine co-treated with bitertanol co-treated with cypermethrin co-treated with Malathion] inhibits the reaction [Triiodothyronine results in increased cell proliferation] 1: Rattus norvegicus Pituitary Gland | Cell Line, Tumor
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
40. Triiodothyronine cell proliferation cypermethrin | Malathion | prothioconazole | terbutylazine [prothioconazole co-treated with terbutylazine co-treated with cypermethrin co-treated with Malathion] promotes the reaction [Triiodothyronine results in increased cell proliferation] 1: Rattus norvegicus Pituitary Gland | Cell Line, Tumor
36 genes: ACE | ACVR2A | AKT1 | BAD | BAX | BCL2 | BCL2L1 | CDK1 | CDK7 | CYP1A1 | EMP1 | FGF1 | FGF18 | FGF2 | FPGS | GH1 | GLI2 | HTR1A | IGF1 | INSIG1 | IRS2 | KRT16 | MKI67 | MYC | PCNA | PRDM4 | PRKDC | PRL | SRC | TACC3 | TGFB1 | THPO | TNF | TP63 | TXNRD1 | TYR
1
41. Triiodothyronine fat cell differentiation 1-Methyl-3-isobutylxanthine | Dexamethasone | Hydrocortisone | INS | Rosiglitazone | TF [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Hydrocortisone co-treated with Triiodothyronine co-treated with TF protein co-treated with INS protein] results in increased fat cell differentiation 1: Homo sapiens Adipose Tissue
5 genes: CCND1 | INHBB | NR4A1 | SREBF1 | WNT5B
1
42. Triiodothyronine regulation of thyroid hormone receptor activity Triiodothyronine results in increased regulation of thyroid hormone receptor activity 1: Rattus norvegicus Pituitary Gland | Cell Line, Tumor   1
43. Triiodothyronine regulation of thyroid hormone receptor activity SJ 000311413 SJ 000311413 inhibits the reaction [Triiodothyronine results in increased regulation of thyroid hormone receptor activity] 1: Rattus norvegicus Pituitary Gland | Cell Line, Tumor   1
44. Triiodothyronine regulation of thyroid hormone receptor activity (4-(4-hydroxy-3-isopropyl-5-(4-nitrophenylethynyl)benzyl)-3,5-dimethylphenoxy)acetic acid (4-(4-hydroxy-3-isopropyl-5-(4-nitrophenylethynyl)benzyl)-3,5-dimethylphenoxy)acetic acid inhibits the reaction [Triiodothyronine results in increased regulation of thyroid hormone receptor activity] 1: Rattus norvegicus Pituitary Gland | Cell Line, Tumor   1
45. Triiodothyronine brown fat cell differentiation 1-Methyl-3-isobutylxanthine | Dexamethasone | INS1 | Rosiglitazone [Triiodothyronine co-treated with Rosiglitazone co-treated with INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased brown fat cell differentiation 1: Mus musculus 3T3-L1 Cells
9 genes: ADRB1 | ADRB2 | ADRB3 | FABP4 | NUDT7 | PPARGC1A | SCD1 | SLC2A4 | UCP1
1
46. Triiodothyronine brown fat cell differentiation 1-Methyl-3-isobutylxanthine | Dexamethasone | Indomethacin | INS1 | Resveratrol Resveratrol affects the reaction [[INS1 protein co-treated with Triiodothyronine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased brown fat cell differentiation] 1: Mus musculus Adipose Tissue, White | Stromal Cells | Cells, Cultured
9 genes: ADRB1 | ADRB2 | ADRB3 | FABP4 | NUDT7 | PPARGC1A | SCD1 | SLC2A4 | UCP1
1
47. Triiodothyronine positive regulation of sequestering of triglyceride 1-Methyl-3-isobutylxanthine | Dexamethasone | Indomethacin | INS1 | Resveratrol Resveratrol inhibits the reaction [[INS1 protein co-treated with Triiodothyronine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased positive regulation of sequestering of triglyceride] 1: Mus musculus Adipose Tissue, White | Stromal Cells | Cells, Cultured 1 gene: LPL 1
48. Triiodothyronine brown fat cell differentiation 1-Methyl-3-isobutylxanthine | Dexamethasone | Indomethacin | INS1 [INS1 protein co-treated with Triiodothyronine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased brown fat cell differentiation 1: Mus musculus Adipose Tissue, White | Stromal Cells | Cells, Cultured
9 genes: ADRB1 | ADRB2 | ADRB3 | FABP4 | NUDT7 | PPARGC1A | SCD1 | SLC2A4 | UCP1
1
49. Triiodothyronine positive regulation of sequestering of triglyceride 1-Methyl-3-isobutylxanthine | Dexamethasone | Indomethacin | INS1 [INS1 protein co-treated with Triiodothyronine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased positive regulation of sequestering of triglyceride 1: Mus musculus Adipose Tissue, White | Stromal Cells | Cells, Cultured 1 gene: LPL 1
50. Triiodothyronine positive regulation of brown fat cell differentiation 1-Methyl-3-isobutylxanthine | Dexamethasone | Indomethacin | INS1 | PRKAA1 PRKAA1 gene mutant form inhibits the reaction [[INS1 protein co-treated with Triiodothyronine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased positive regulation of brown fat cell differentiation] 1: Mus musculus Adipose Tissue, White | Stromal Cells | Cells, Cultured 1 gene: INS 1
1–50 of 166 results.